Baidu
map
J BONE ONCOL 润色咨询

Journal of Bone Oncology

出版年份:暂无数据 年文章数:398 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:16.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2024-06-08 故乡的云 来自广东省

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2023-06-21 Big Hero 来自上海

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:骨肿瘤
    经验分享:季刊,发文量太小了,很难

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2019-10-30 医心唯你

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2020-07-05 mswert122

    今年回三分了,3.066

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2019-10-30 医心唯你

    不过if跌出三分档了,单位奖励减半了医心唯你 2019-10-30 00:00:00 发表:
    历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。

    医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2019-06-11 医心唯你

    季刊,发文量太小了,很难

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2018-12-14 1e23313dm78(暂无匿称)

    兄弟,结果怎么样joycelee 2017-05-09 10:27:00 发表:
    1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了

    joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2018-07-09 DocterSunshine

    这个杂志好不好中?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2018-06-27 peterux

    明明是3.5分,显示被除名。重大失误!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2208944, encodeId=5e44220894466, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:投稿两次感觉数据量足够但是悲催了,每次历时2个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Sat Jun 08 14:37:35 CST 2024, time=2024-06-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2144060, encodeId=06782144060a7, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:骨肿瘤<br>经验分享:季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91252243698, createdName=Big Hero, createdTime=Wed Jun 21 10:12:06 CST 2023, time=2023-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=579091, encodeId=8eaa5e909158, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801371, encodeId=3b158013e1a0, content=今年回三分了,3.066, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Sun Jul 05 21:21:41 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579092, encodeId=a5da5e909208, content=不过if跌出三分档了,单位奖励减半了<span class="quote">医心唯你 2019-10-30 00:00:00 发表:<br>历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。</span>, beContent=医心唯你 2019-10-30 00:00:00 发表: 历时半年中了一篇综述,通过来往邮件来看,主编人挺好,给了我三次返修机会,其中最后两次都是改语言。对语言要求极其严格,找了俩老外给润色才过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Wed Oct 30 00:00:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572147, encodeId=3f085e214730, content=季刊,发文量太小了,很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Tue Jun 11 18:40:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564451, encodeId=4bc0564451d6, content=兄弟,结果怎么样<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised,等结果中,保佑,拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48992030427, createdName=1e23313dm78(暂无匿称), createdTime=Fri Dec 14 00:00:00 CST 2018, time=2018-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559021, encodeId=d91055902126, content=这个杂志好不好中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc1635944, createdName=DocterSunshine, createdTime=Mon Jul 09 13:14:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558523, encodeId=ebdd5585237e, content=明明是3.5分,显示被除名。重大失误!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3c81639484, createdName=peterux, createdTime=Wed Jun 27 20:13:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551686, encodeId=0bba55168643, content=后来接受了吗?<span class="quote">joycelee 2017-05-09 10:27:00 发表:<br>1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了</span>, beContent=joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Jan 19 00:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2018-01-19 sunliang

    后来接受了吗?joycelee 2017-05-09 10:27:00 发表:
    1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了

    joycelee 2017-05-09 10:27:00 发表: 1-16:submit;1-30:underreview,4-7:major;5-9:revised.等结果中.保佑.拒得无路可走了

    0

共13条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map